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Abstract
Background: Clear cell odontogenic carcinoma is a rare odontogenic tumor occurring in the
anterior region of the mandible in 5th–7th decades and shows a female preponderance. It is
potentially aggressive, capable of frequent recurrences and loco-regional and distant metastases.
Case presentation: A 45- year- old woman presented with a radiolucent left mandibular swelling
associated with loss of teeth. Left cervical lymph nodes were enlarged on palpation. The patient
underwent resection of the tumor but consequent to resected margins being positive for tumor
cells underwent left hemimandibulectomy with ipsilateral functional neck dissection and was free
of recurrence at 8 months follow-up.
Conclusion: Clear cell odontogenic carcinoma should be considered in the differential diagnosis
of jaw tumors with conspicuous clear cell component. Curettage or conservative resection
inevitably results in recurrences and/or metastasis and more radical resection is warranted in these
tumors, especially when they are large and show soft tissue invasion.
Background
Clear cell odontogenic carcinoma (CCOC) is a rare odon-
togenic tumor arising from the anterior region of mandi-
ble and has a predilection for females with 43 cases
reported in literature. We report a case of CCOC in the
mandible of a 45- year- old female with lymph node
metastasis
Case presentation
A 45-year-old woman presented with a painful swelling
on the left side of her jaw of 5 months duration. The swell-
ing had recently started to grow rapidly. There were no
associated sensory symptoms. In addition, a few teeth
adjacent to the swelling had become loose, carious and
had fallen off. Local physical examination showed a 4.0 ×
3.2 × 3.0 cm, tender, firm, irregular lump that appeared to
arise from the left mandible. Intra orally, the tumor could
be seen as a pink, bulging and fleshy mass. Two lymph
nodes were palpable, one in left submaxillary region
measuring approximately 1 × 1 cm and the other in the
left cervical region and was barely palpable. Remainder of
the physical examination was not contributory and no
other swelling was noticed. Orthopantomogram (OPG)
of the jaw showed a radiolucent lesion with irregular mar-
gins, centered in and destroying a portion of the left man-
dibular body (Figure 1). The teeth adjacent to the mass
were carious and some were missing. A computed tomog-
raphy (CT) scan of the oral cavity and neck was advised
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but was not done due to financial reasons. A clinical diag-
nosis of ameloblastoma with suspicion of lymph node
involvement was given.
Pathological findings
An incisional biopsy of the lesion was submitted for path-
ologic evaluation. Microscopic examination of the tissue
showed a neoplasm composed of epithelial cells arranged
in irregular nests separated by fibrovascular septa. The
cells adjacent to the fibrovascular septa were cuboidal to
columnar with high nuclear-cytoplasmic ratio and eosi-
nophilic cytoplasm, while those in the center of the nests
were larger and polygonal, with abundant clear cytoplasm
(Figure 2). Each cell had a single nucleus with fine chro-
matin and prominent eosinophilic nucleolus. The cells at
the periphery of the nests occasionally demonstrated
nuclear palisading away from the basement membrane,
i.e., reverse nuclear polarity (Figure 3). These peripheral
cells also showed occasional mitoses. The central areas of
the nests and fibrous septae showed infiltration by neu-
trophils. The cells were immunoreactive for pan-cytokera-
tin, epithelial membrane antigen, and S-100 protein; they
did not stain for vimentin, smooth muscle actin, and
HMB-45. The abundant, clear cytoplasm of the cells was
strongly positive for periodic acid-Schiff (PAS) (Figure
4a). This PAS positivity was diastase sensitive indicating
intracytoplasmic glycogen (Figure 4b). A diagnosis of
clear cell odontogenic carcinoma was entertained. Fine
needle aspiration from the submaxillary node was done
but was inconclusive.
The patient was referred to a specialty cancer hospital
where she underwent left hemimandibulectomy with
ipsilateral functional neck dissection (level1 to level 5).
The reconstruction was done using ipsilateral 12th rib and
the soft tissue coverage was given by pectoralis major flap.
Postoperative histopathological examination showed
tumor morphology similar to incisional biopsy and 1/11
lymph nodes (submaxillary) was positive for the tumor
metastasis without any extranodal spread. The tumor was
extending into the soft tissue and the left bony margin was
positive for the tumor cells. Due to the positive margin,
the patient was referred for adjuvant radiotherapy for
which she refused to give consent. At the time of discharge
the patient was accepting soft diet and the suture line on
the neck and chest were healthy. Subsequent to the dis-
charge, the patient was lost to follow-up only to reappear
after 8 months and at that time had no signs of local or
regional spread. Since then patient is again lost to follow-
up.
Section showing palisaded cells with reverse nuclear polarity  (H&E, ×400) Figure 3
Section showing palisaded cells with reverse nuclear polarity 
(H&E, ×400).
OPG showing a radiolucent lesion with irregular bony mar- gins, partly destroying the left mandibular body (arrow) Figure 1
OPG showing a radiolucent lesion with irregular bony mar-
gins, partly destroying the left mandibular body (arrow).
Section showing central clear cells separated by fibrovascular  septae (H&E, ×100) Figure 2
Section showing central clear cells separated by fibrovascular 
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Discussion
In 1985, Hansen et al., reported a locally aggressive odon-
togenic neoplasm, and named it clear cell odontogenic
tumor [1]. This neoplasm was initially thought to be
devoid of malignant potential and classified as benign [2].
Subsequent reports of their aggressive behavior, predilec-
tion for local recurrence, evidence of pulmonary and
lymph node metastases and tumor-related deaths necessi-
tated a change in their classification and nomenclature
and is now called CCOC [3-7].
The classic clinical presentation of CCOC is a painful
anterior mandibular swelling in an elderly woman. There
may be loosening of adjacent teeth, and a roentgenogram
shows an irregular radiolucent mass, most often in a pre-
molar location. Histopathologically, CCOCs may show
one or more of three architectural patterns: biphasic,
monophasic, and ameloblastomatous. The most com-
mon biphasic pattern of tumor growth comprises of nests
of cells with clear cytoplasm admixed with cells contain-
ing eosinophilic cytoplasm. The monophasic pattern
comprises only of clear cells, while the ameloblastoma-
tous pattern resembles the growth pattern of ameloblast-
oma with nests of cells showing central cystic change and
squamous differentiation, and peripheral nuclear palisad-
ing with reverse polarity [7]. The differential diagnosis of
jaw tumors with prominent cytoplasmic clearing includes
intraosseous salivary gland tumors (epithelial-myoepithe-
lial carcinoma, in which the clear myoepithelial cells are
immunoreactive for S-100 protein, vimentin, smooth
muscle actin, and calponin; mucoepidermoid carcinoma,
distinguished by its triphasic architecture comprised of
mucin-positive mucous cells, squamoid cells, and inter-
mediate cells) and metastatic tumors (classic clear cell
renal cell carcinoma, which can be identified by its char-
acteristically rich vascular pattern and its immunoreactiv-
ity for cytokeratins and vimentin and lack of reactivity for
S-100 protein; and amelanotic melanoma, which reacts
for HMB-45, S-100 protein and other melanoma mark-
ers). Other odontogenic tumors may also show clearing of
their constituent cells. Such tumors include calcifying epi-
thelial odontogenic tumor and clear cell ameloblastoma.
While the former is identified by the presence of psam-
momatous calcifications and amyloid deposits, the latter
may be difficult to distinguish from CCOC. In fact, some
authors think that clear cell ameloblastomas and CCOCs
may represent a clinico-pathological continuum of a sin-
gle neoplastic entity [8].
A recent review of literature of the 43 cases reported so far
[9] showed that the male: female ratio was 3:1, mean age
at presentation was 58 years (range 17–89 years), the aver-
age period of follow-up was 5.5 years (range 0.5–21
years), mandible was the most favored location (84%).
The overall recurrence rate for these tumors was 55% and
local recurrence rates were higher (80%) for curettage
alone than for resection alone (43%). Lymph node metas-
tasis on initial presentation was rare (10%) but rapidly
increased in those with recurrent disease (33%). Factors
such as size of the lesion, soft tissue involvement, lymph
node metastasis and most importantly, the presence or
absence of positive surgical margins should be considered
when developing the treatment strategy.
Conclusion
CCOC although rare, should be considered in differential
diagnosis of jaw tumors with prominent clear cell compo-
nent. The limited number of reported cases precludes a
definitive assessment of prognostic factors or efficacy of
therapy in CCOC. Currently, treatment is aimed at achiev-
ing wide surgical resection with tumor-free margins, and
loco-regional control by lymph node resection and local
radiation in cases with extensive soft tissue invasion,
perineural spread, lymph node metastasis with extranodal
involvement or in those where tumor-free margins are not
possible. A long-term follow-up is essential as these
tumors may recur locally or present with late distant
metastases.
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Section showing (a) PAS positive and (b) diastase labile tumor  cells (H&E, ×100) Figure 4
Section showing (a) PAS positive and (b) diastase labile tumor 
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